COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 2678: Articles 26771-26780  | Next

An imperfect tool: COVID-19 'test & trace' success relies on minimising the impact of false negatives and continuation of physical distancing.
Davis, E. L., Lucas, T. C. D., Borlase, A., Pollington, T. M., Abbott, S., Ayabina, D., Crellen, T., Hellewell, J., Pi, L., Medley, G. F., Hollingsworth, T. D., Klepac, P.
10.1101/2020.06.09.20124008 — Posted: 2020-06-12
Oscillations in USA COVID-19 Incidence and Mortality Data reflect societal factors
Bergman, A., Sella, Y., Agre, P., Casadevall, A.
10.1101/2020.06.08.20123786 — Posted: 2020-06-12
Point of care lung ultrasound is useful when screening for CoVid-19 in Emergency Department patients.
Hankins, A., Bang, H., Walsh, P.
10.1101/2020.06.09.20123836 — Posted: 2020-06-12
Differences in antibody kinetics and functionality between severe and mild SARS-CoV-2 infections.
Rijkers, G., Murk, J.-L., Wintermans, B., van Looy, B., van den Berge, M., Veenemans, J., Stohr, J., Reusken, C., van der Pol, P., Reimerink, J.
10.1101/2020.06.09.20122036 — Posted: 2020-06-12 Discussion: Onsite
Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: a retrospective cohort study.
Giacomelli, A., Pagani, G., Ridolfo, A. L., Oreni, A., Conti, F., Pezzati, L., Bradanini, L., Casalini, G., Passerini, S., Torre, A., Cohen, M., Gubertini, G., Rizzardini, G., Cogliati, C., Ceriani, E., Colombo, R., Rusconi, S., Gervasoni, C., Cattaneo, D., Antinori, S., Galli, M.
10.1101/2020.06.05.20123299 — Posted: 2020-06-12
Evaluation of Sample Pooling for Screening of SARS-CoV-2
Mulu, A., Alemayehu, D. H., Alemu, F., Tefera, D. A., Wolde, S., Aseffa, G., Seyoum, T., Habtamu, M., Abdissa, A., Bayih, A. G., Beyene, G. T.
10.1101/2020.06.10.20123398 — Posted: 2020-06-12
Hydroxychloroquine plus standard care compared with the standard care alone in COVID-19: a meta-analysis of randomized controlled trials
Amani, B., Khanijahani, A., Amani, B.
10.1101/2020.06.05.20122705 — Posted: 2020-06-12
A Comparative Study of Target Reconstruction of Ultra-High-Resolution CT for Patients with Corona-Virus Disease 2019 (COVID-19)
Lv, S., Lin, Y., Kang, J., Duan, S., Zhang, W., Wang, J.-a.
10.1101/2020.06.04.20119206 — Posted: 2020-06-12
A Fully Automated Deep Learning-based Network ForDetecting COVID-19 from a New And Large Lung CT ScanDataset
Rahimzadeh, M., Attar, A., Sakhaei, S. M.
10.1101/2020.06.08.20121541 — Posted: 2020-06-12
Estimating the COVID-19 epidemic trajectory and hospital capacity requirements in South West England: a mathematical modelling framework
Booton, R. D., MacGregor, L., Vass, L., Looker, K. J., Hyams, C., Bright, P. D., Harding, I., Lazarus, R., Hamilton, F., Lawson, D., Danon, L., Pratt, A., Wood, R., Brooks-Pollock, E., Turner, K. M. E.
10.1101/2020.06.10.20084715 — Posted: 2020-06-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).